Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Development Delay clinical trials

3 of 6 indexed Development Delay trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Development Delay: 6 US clinical trials tracked, 3 recruiting.

Development Delay is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Royal Devon and Exeter NHS Foundation Trust, running 1 of these trials.

Enrollment posture brief

Registry condition development-delay

OPEN 3 | RECR 50% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Development Delay (this)50%
Open-enrollment share among volume-matched conditions near Development Delay

Development Delay lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Development Delay on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Development Delay is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Development Delay research.

    Royal Devon and Exeter NHS Foundation Trust accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Development Delay trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Development Delay splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Development Delay records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Family Advice and Support Text and Telephone (FASTT) program Behavioral
1 trials
Standard Children's Learning Center (CLC) Program Behavioral
1 trials
Family Nurture Intervention (FNI) Behavioral
1 trials
Power Wheelchair Standing Device Device
1 trials
Center Based or In Home Early Intervention Program Behavioral
1 trials
Sulfonylurea Drug
1 trials
Induced Pluripotential Stem Cells Other
1 trials
Brain Magnetic Resonance Imaging (MRI) Diagnostic test
1 trials

US sites by state

Facility locations filed on Development Delay trials. A trial with sites in several states counts in each.

California 2 trials
Oregon 1 trials
Missouri 1 trials
Michigan 1 trials
Illinois 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Development Delay page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Development Delay condition card totals 6 registered trials; most-linked intervention Family Advice and Support Text and Telephone (FASTT) program; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.